EUVIMEDEUVIMED entdecken
Klinische Studie (Phase II)Klinische Studie (Phase III)Multizentrische StudieOpen Access

Hematologic Cancer after Gene Therapy for Cerebral Adrenoleukodystrophy

Christine N Duncan, Jacob R Bledsoe, Bartosz Grzywacz, Amy Beckman, Melissa Bonner, Florian S Eichler, Jörn-Sven Kühl, Marian H Harris, Sarah Slauson, Richard A Colvin, Vinod K Prasad, Gerald F Downey und 11 weitere

New England Journal of Medicine · 10.10.2024 · 391 (14) · 1287-1301

DOI: 10.1056/nejmoa2405541 ↗

Kurz gefasst

Klinische Studie (Phase II) in der Zeitschrift New England Journal of Medicine, erschienen am 10.10.2024. Verfasst von Christine N Duncan und 22 weiteren Autor:innen. Beteiligte Einrichtung: From Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Harvard Medical School (C.N.D., D.A.W.), the Department of Pathology, Boston Ch…. Hauptthemen laut MEDLINE: Adrenoleukodystrophy, Genetic Therapy, Genetic Vectors, Hematologic Neoplasms. Die Arbeit wurde bisher 166-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NINDS NIH HHS, Bluebird Bio.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AdrenoleukodystrophyGenetic TherapyGenetic VectorsHematologic NeoplasmsLentivirusAdolescentChildFemaleHumansMaleATP Binding Cassette Transporter, Subfamily D, Member 1Clonal EvolutionFollow-Up StudiesMyelodysplastic Syndromes

Substanzen

ABCD1 protein, humanATP Binding Cassette Transporter, Subfamily D, Member 1

Autor:innen und Institutionen

  • From Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Harvard Medical School (C.N.D., D.A.W.), the Department of Pathology, Boston Children's Hospital (J.R.B., M.H.H.), and Massachusetts General Hospital…

ORCID-Profile: David A Williams

Förderung

  • NINDS NIH HHS
  • Bluebird Bio

Zitieren

APA

Duncan, C. N., Bledsoe, J. R., Grzywacz, B., Beckman, A., Bonner, M., Eichler, F. S., Kühl, J. S., Harris, M. H., Slauson, S., Colvin, R. A., Prasad, V. K., Downey, G. F., Pierciey, F. J., Kinney, M. A., Foos, M., Lodaya, A., Floro, N., Parsons, G., Dietz, A. C., …, & Williams, D. A. (2024). Hematologic Cancer after Gene Therapy for Cerebral Adrenoleukodystrophy. New England Journal of Medicine, 391(14), 1287-1301. https://doi.org/10.1056/nejmoa2405541

Vancouver

Duncan CN, Bledsoe JR, Grzywacz B, Beckman A, Bonner M, Eichler FS, et al. Hematologic Cancer after Gene Therapy for Cerebral Adrenoleukodystrophy. New England Journal of Medicine. 2024;391(14):1287-1301. doi:10.1056/nejmoa2405541

BibTeX
@article{Duncan2024,
  author = {Duncan, Christine N and Bledsoe, Jacob R and Grzywacz, Bartosz and Beckman, Amy and Bonner, Melissa and Eichler, Florian S and Kühl, Jörn-Sven and Harris, Marian H and Slauson, Sarah and Colvin, Richard A and Prasad, Vinod K and Downey, Gerald F and Pierciey, Francis J and Kinney, Melissa A and Foos, Marianna and Lodaya, Ankit and Floro, Nicole and Parsons, Geoffrey and Dietz, Andrew C and Gupta, Ashish O and Orchard, Paul J and Thakar, Himal L and Williams, David A},
  title = {Hematologic Cancer after Gene Therapy for Cerebral Adrenoleukodystrophy},
  journal = {New England Journal of Medicine},
  year = {2024},
  volume = {391},
  number = {14},
  pages = {1287--1301},
  doi = {10.1056/nejmoa2405541}
}
Kostenlos starten →